 | Phathom Pharmaceuticals, Inc. | |||
| NMS : PHAT || Location: United States | ||||
$9.18+0.08 (+0.88%) |
0.37 M | 8.97 - 9.43 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 12.032 M |
| March 28, 2024 | 10.647 M |
| March 15, 2024 | 10.444 M |
| Feb. 29, 2024 | 8.672 M |
| Feb. 15, 2024 | 9.253 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.10 | -1.39 | -26.54% |
| 09/30/2023 | -0.91 | -0.76 | 16.42% |
| 06/30/2023 | -1.00 | -0.84 | 15.84% |
| 03/31/2023 | -1.29 | -0.89 | 30.78% |
| 12/31/2022 | -1.38 | -1.33 | 3.53% |
PHAT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 58.524M | Shares Float | 43.230M |
| Short Float | 12.032M | Market Cap | 532.57M |
| Institution ownership | 88.60% | Insider ownership | 8.917% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.93 | Forward EPS | -3.24 |